Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by SanFrancisco99on May 08, 2014 9:45am
241 Views
Post# 22537884

RE:RE:RE:RE:RE:RE:RVX - EVENTS/WEBCASTS section updated...

RE:RE:RE:RE:RE:RE:RVX - EVENTS/WEBCASTS section updated...I guess the rumours I have been hearing are quite different about the office move.

I have heard that it is a cost increase/expansion and not a cost-cutting move.  I have further heard that a very impressive new laboratory is being fitted out in the new digs.   Such things are not inexpensive to create - and are the sort of thing a company on the move does - one expanding and not contracting.

I don't live in Calgary.  Somebody who does out to get in their car and go check out the new building from the exterior.  Then they ought to walk in and at least see the lobby during business hours - you can learn a lot from even that.  Bring your iPhone and take a few photos to share on Stockhouse.  

I would venture a guess that the company might even be willing to give you a very brief look-see, although you never know about that.

Looks to me more like expansion and not contraction.  Bodes well for what might be happening behind the scenes perhaps.




Bullboard Posts